Myricetin served as antagonist for negatively regulate MRGPRX2 mediated pseudo-allergic reactions through CD300f/SHP1/SHP2 phosphorylation.
Release Time:2025-04-30
Hits:
- Date:
- 2025-04-30
- Title of Paper:
- Myricetin served as antagonist for negatively regulate MRGPRX2 mediated pseudo-allergic reactions through CD300f/SHP1/SHP2 phosphorylation.
- Journal:
- International Immunopharmacology
- Co-author:
- Baowen Dang, Shiting Hu, Yonghui Zhang, Yihan Huang, Tao Zhang*, Hongli An*
- Volume:
- 118
- Page Number:
- 110034
- Translation or Not:
- No
- Date of Publication:
- 2023-05-01
- Prev One:Alpha-linolenic acid improves nasal mucosa epithelial barrier function in allergic rhinitis by arresting CD4+ T cell differentiation via IL-4Ralpha-JAK2-STAT3 pathway.
- Next One:A rapid, accurate, and low-cost method for detecting Mycobacterium tuberculosis and its drug-resistant genes in pulmonary tuberculosis: Applications of MassARRAY DNA mass spectrometry.